Skip to main content
Caplight Logo









Nirvana

Nirvana

Private
New York City, New YorkHealthcare & Life Scienceshttps://meetnirvana.com

Last Round

Series A

Sep 12, 2024

Total Funding Raised

$35.9M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Nirvana operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series A round in September 2024.

Nirvana is a healthtech company that provides an AI-powered insurance intelligence platform to automate eligibility checks and cost-share estimates for healthcare providers.

Sector

Healthcare & Life Sciences

Verticals

Revenue Cycle, Mental Health, API Management, Workflow Automation, InsurTech

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Nirvana Comparables

Compare Nirvana with similar companies based on industry and business-model similarity.

Nirvana comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Eligible
82%
VerifyTreatment
76%
Stedi
75%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Nirvana Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 12, 2024
SeedNov 17, 2021
SeedAug 9, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Urvish Parikh

Co-Founder CTO

Founding Team

Kelvin K Chan

Co-Founder and CEO

Founding Team

Pooneet Kant

Chief Operating Officer

Executive Team

For institutional investors. Book with your work email.

Nirvana Investors

Notable investors and investment history

Nirvana investors
InvestorRounds
Everywhere VenturesSeries A
Eniac VenturesSeries A, Seed
NorthzoneSeries A
Surface VenturesSeries A
Inspired CapitalSeries A, Seed
Arc VenturesSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 39% MoM.

  • Apr 23, 2026

    Added Televero Health, Inc. as a customer.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • receives_awardSep 28, 2026

    At the 2026 VMAs on Sep 28th '26, Meet Nirvana receives the Video Vanguard Award.

Book a demo to see all news

For institutional investors. Book with your work email.

Nirvana Filings

Explore SEC and related filing metadata, where available.

Nirvana filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Nirvana's valuation, stock price, and market status.

Is Nirvana a public or private company?

Nirvana is a private company.

What is the current stock price of Nirvana?

Nirvana is a private company, so its shares have no public market price. Caplight tracks Nirvana's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Nirvana worth (valuation)?

Valuation information for Nirvana is not publicly available.

Can I buy Nirvana stock?

Nirvana shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Nirvana's last funding round?

Nirvana's most recent funding round was Series A on September 12, 2024.

Who are the main investors in Nirvana?

Key investors in Nirvana include Eniac Ventures, Northzone, Inspired Capital, Arc Ventures.

Will Nirvana IPO soon?

No public IPO plans have been announced for Nirvana.

How can I track Nirvana secondary market activity?

Caplight tracks bids, offers, and trades in Nirvana's shares on secondary markets.

Firmographic Details

HeadquartersNew York City, New York
Employee Range47
Year Founded2020
Last FundingSep 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?